Reporter June 7 2019
Steroid binding to metabolic enzyme
Jun. 12, 2019—Understanding how a steroid-metabolizing enzyme binds to its substrates may aid in designing drugs to treat sexual dysfunction as well as prostate cancer.
Cell-cell signals in developing heart
Jun. 10, 2019—Scott Baldwin and colleagues have discovered early signaling events during heart development, findings that could guide cell replacement therapies for heart disease.
Dmochowski Receives AUA’s Victor A. Politano Award
Jun. 7, 2019—VUMC's Dmochowski Receives AUA’s Victor A. Politano Award
AMA grant to enhance resident training across nation
Jun. 6, 2019—Vanderbilt University Medical Center is one of eight award recipients that will receive funding from the American Medical Association (AMA) as part of its new Reimagining Residency initiative.
VUMC joins international effort to speed vaccine development
Jun. 6, 2019—VUMC has joined an international effort to streamline and accelerate development of vaccines and other treatments against a growing worldwide surge of deadly and debilitating viral infections.
Mouth microbes and colorectal cancer
Jun. 6, 2019—Microbial species in the mouth could be playing a role in colorectal cancer development, according to new research from epidemiologists at VUMC.
Immunotherapy helping 87-year-old man stay on the job
Jun. 6, 2019—Nine years after being diagnosed with metastatic lung cancer, Roszell Mack Jr., 87, still goes into the office every day thanks to a durable response to the immunotherapy pembrolizumab.
Treating core Rett syndrome symptoms
Jun. 6, 2019—A new study published in Neurology reports the drug trofinetide has proven safe and effective in treating core symptoms of Rett syndrome in female children and adolescents.
Study sheds light on importance of comprehension when obtaining consent
Jun. 6, 2019—Bioethics study focuses on comprehension of informed consent for research
VUMC’s Specialty Pharmacy nominated for Patient Choice Award
Jun. 6, 2019—VUMC's Specialty Pharmacy has been selected as a finalist for a 2019 Patient Choice Award.
Custom stents saving smiles for some oral cancer patients
Jun. 6, 2019—When Laura McClure-Barnes, MD, learned she needed radiation therapy following surgery for adenoid cystic carcinoma, a rare cancer of the salivary glands, she knew that radiation could damage healthy tissue and bone near the tumor.
Faculty meeting highlights VUSM’s academic successes
Jun. 6, 2019—Jeff Balser, MD, PhD, President and CEO of Vanderbilt University Medical Center and Dean of Vanderbilt University School of Medicine, kicked off the Spring Faculty Meeting by providing a short update of VUSM’s academic endeavors.
